Matthew C Kapusta - Net Worth and Insider Trading
Matthew C Kapusta Net Worth
The estimated net worth of Matthew C Kapusta is at least $11 Million dollars as of 2024-12-28. Matthew C Kapusta is the CEO, Managing Director of uniQure NV and owns about 597,915 shares of uniQure NV (QURE) stock worth over $10 Million. Matthew C Kapusta is also the SVP, Business Development of AngioDynamics Inc and owns about 27,005 shares of AngioDynamics Inc (ANGO) stock worth over $240,615. Details can be seen in Matthew C Kapusta's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew C Kapusta has not made any transactions after 2024-12-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthew C Kapusta
Matthew C Kapusta Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew C Kapusta owns 3 companies in total, including uniQure NV (QURE) , AngioDynamics Inc (ANGO) , and Decibel Therapeutics Inc (DBTX) .
Click here to see the complete history of Matthew C Kapusta’s form 4 insider trades.
Insider Ownership Summary of Matthew C Kapusta
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| QURE | uniQure NV | 2024-12-10 | director & CEO & Managing Director |
| ANGO | AngioDynamics Inc | 2014-04-14 | SVP & Business Development |
| DBTX | Decibel Therapeutics Inc | 2023-03-19 | director |
Matthew C Kapusta Latest Holdings Summary
Matthew C Kapusta currently owns a total of 2 stocks. Among these stocks, Matthew C Kapusta owns 597,915 shares of uniQure NV (QURE) as of December 10, 2024, with a value of $10 Million and a weighting of 97.75%. Matthew C Kapusta also owns 27,005 shares of AngioDynamics Inc (ANGO) as of April 14, 2014, with a value of $240,615 and a weighting of 2.25%.
Latest Holdings of Matthew C Kapusta
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| QURE | uniQure NV | 2024-12-10 | 597,915 | 17.50 | 10,463,513 |
| ANGO | AngioDynamics Inc | 2014-04-14 | 27,005 | 8.91 | 240,615 |
Holding Weightings of Matthew C Kapusta
Matthew C Kapusta Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew C Kapusta has made a total of 32 transactions in uniQure NV (QURE) over the past 5 years, including 0 buys and 32 sells. The most-recent trade in uniQure NV is the sale of 100,000 shares on December 10, 2024, which brought Matthew C Kapusta around $2 Million.
According to the SEC Form 4 filings, Matthew C Kapusta has made a total of 0 transactions in AngioDynamics Inc (ANGO) over the past 5 years. The most-recent trade in AngioDynamics Inc is the acquisition of 1,000 shares on April 14, 2014, which cost Matthew C Kapusta around $13,900.
Insider Trading History of Matthew C Kapusta
- 1
Matthew C Kapusta Trading Performance
GuruFocus tracks the stock performance after each of Matthew C Kapusta's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew C Kapusta is 3.35%. GuruFocus also compares Matthew C Kapusta's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew C Kapusta within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Matthew C Kapusta's insider trading performs compared to the benchmark.
Performance of Matthew C Kapusta
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.07 | | | | | |
| Relative Return to S&P 500(%) | 0.51 | | | | | |
Matthew C Kapusta Ownership Network
Matthew C Kapusta Owned Company Details
What does uniQure NV do?
Who are the key executives at uniQure NV?
Matthew C Kapusta is the director & CEO & Managing Director of uniQure NV. Other key executives at uniQure NV include Chief Financial Officer Christian Klemt , Chief Medical Officer Walid Abi-saab , and Chief Operating Officer Pierre Caloz .
uniQure NV (QURE) Insider Trades Summary
Over the past 18 months, Matthew C Kapusta made 3 insider transaction in uniQure NV (QURE) with a net sale of 131,322. Other recent insider transactions involving uniQure NV (QURE) include a net sale of 27,508 shares made by Pierre Caloz , a net sale of 19,313 shares made by Christian Klemt , and a net sale of 5,841 shares made by Ricardo Dolmetsch .
In summary, during the past 3 months, insiders sold 105,214 shares of uniQure NV (QURE) in total and bought 0 shares, with a net sale of 105,214 shares. During the past 18 months, 209,288 shares of uniQure NV (QURE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 209,288 shares.
uniQure NV (QURE)'s detailed insider trading history can be found in Insider Trading Tracker table.
uniQure NV Insider Transactions
Matthew C Kapusta Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew C Kapusta. You might contact Matthew C Kapusta via mailing address: 7358 Mcvay Road, Germantown Tn 38138.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
